Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome.
Bleb-independent filtering surgery
Glaucoma
Intraocular pressure
Iridocorneal endothelial syndrome
Penetrating canaloplasty
Retrocorneal membrane interception
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
26 Sep 2024
26 Sep 2024
Historique:
received:
17
04
2023
accepted:
15
06
2024
medline:
26
9
2024
pubmed:
26
9
2024
entrez:
26
9
2024
Statut:
epublish
Résumé
To assess the efficacy and safety of retrocorneal membrane interception (RMI)-enhanced penetrating canaloplasty in glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE) with open angle or small peripheral anterior synechiae (PAS). A series of 13 patients (13 eyes) with GS-ICE and uncontrolled intraocular pressure (IOP) underwent RMI-enhanced penetrating canaloplasty from March 2019 to October 2020. The patients were followed up at one week, 1 month, 3 months, 6 months, and 12 months, postoperatively. The main outcome measure was surgical success, which was defined as an IOP ≤ 18 mmHg or ≤ 21 mmHg, with glaucoma medications (qualified success), or without glaucoma medications (complete success). Secondary outcome measures were IOP, medication usage, and surgical complications. Among the 13 GS-ICE eyes, 12 (92%) achieved qualified success and 10 (77%) achieved complete success at 12 months postoperatively. The mean IOP decreased from 36.41 ± 8.92 mmHg on 3.0 (IQR 0.5) medications before surgery to 17.09 ± 7.71 mmHg (p = 0.0004) on 0.0 (IQR 0.5) medications (p = 0.0004) at 12 months after surgery. Transient hypotony (38%) and hyphema (38%) were the most common complications. RMI-enhanced penetrating canaloplasty appears effective and safe in treating GS-ICE with open angle or small PAS up to one year of follow up.
Identifiants
pubmed: 39325075
doi: 10.1007/s10792-024-03211-9
pii: 10.1007/s10792-024-03211-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
395Subventions
Organisme : the Key Research and Development Projects of Zhejiang Province
ID : 2022C03112
Organisme : the National Key Research and Development Project of China
ID : 2020YFC2008200
Organisme : the Program for Zhejiang Leading Talent of S&T Innovation
ID : 2021R52012
Organisme : the Zhejiang Provincial Program for the Cultivation of Leading Talents in Colleges and Universities
ID : 2020099
Organisme : the Foundation for Scientific Research and Development of Wenzhou Medical University
ID : QTJ13009
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Shields MB (1979) Progressive essential iris atrophy, Chandler’s syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol 24:3–20. https://doi.org/10.1016/0039-6257(79)90143-7
doi: 10.1016/0039-6257(79)90143-7
pubmed: 483159
Walkden A, Au L (2018) Iridocorneal endothelial syndrome: clinical perspectives. Clin Ophthalmol 12:657–664. https://doi.org/10.2147/opth.S143132
doi: 10.2147/opth.S143132
pubmed: 29670326
pmcid: 5898599
Silva L, Najafi A, Suwan Y et al (2018) The iridocorneal endothelial syndrome. Surv Ophthalmol 63:665–676. https://doi.org/10.1016/j.survophthal.2018.01.001
doi: 10.1016/j.survophthal.2018.01.001
pubmed: 29331589
Sacchetti M, Mantelli F, Marenco M et al (2015) Diagnosis and management of iridocorneal endothelial syndrome. Biomed Res Int 2015:763093. https://doi.org/10.1155/2015/763093
doi: 10.1155/2015/763093
pubmed: 26451377
pmcid: 4588350
Imamoglu S, Sevim MS, Yildiz HE et al (2017) Surgical outcomes of patients with iridocorneal endothelial syndrome: a case series. Int Ophthalmol 37:607–613. https://doi.org/10.1007/s10792-016-0317-1
doi: 10.1007/s10792-016-0317-1
pubmed: 27495952
Chandran P, Rao HL, Mandal AK et al (2017) Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects. PLoS ONE 12:e0171884. https://doi.org/10.1371/journal.pone.0171884
doi: 10.1371/journal.pone.0171884
pubmed: 28282413
pmcid: 5345787
Lanzl IM, Wilson RP, Dudley D et al (2000) Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. Ophthalmology 107:295–297. https://doi.org/10.1016/s0161-6420(99)00077-9
doi: 10.1016/s0161-6420(99)00077-9
pubmed: 10690828
Jain VK, Sharma R, Ojha S et al (2016) Trabeculectomy with mitomycin-C in patients with iridocorneal endothelial syndrome: a case series. J Clin Diagn Res 10:05–06. https://doi.org/10.7860/JCDR/2016/16506.7782
doi: 10.7860/JCDR/2016/16506.7782
Chandran P, Rao HL, Mandal AK et al (2016) Outcomes of primary trabeculectomy with mitomycin-C in glaucoma secondary to iridocorneal endothelial syndrome. J Glaucoma 25:e652-656. https://doi.org/10.1097/IJG.0000000000000268
doi: 10.1097/IJG.0000000000000268
pubmed: 25943731
Mao Z, Guo X, Zhong Y et al (2021) Surgical outcomes of Ahmed glaucoma valve implantation in patients with glaucoma secondary to iridocorneal endothelial syndrome. Eye (Lond) 35:608–615. https://doi.org/10.1038/s41433-020-0912-2
doi: 10.1038/s41433-020-0912-2
pubmed: 32367005
Gebremichael BG, Mohamed A, Chaurasia S et al (2020) Outcomes of Ahmed glaucoma drainage implant in eyes with glaucoma secondary to iridocorneal endothelial syndrome. J Glaucoma 29:567–571. https://doi.org/10.1097/ijg.0000000000001504
doi: 10.1097/ijg.0000000000001504
pubmed: 32251072
Colás-Tomás T, López Tizón E (2020) Ex-PRESS mini-shunt implanted in a pregnant patient with iridocorneal endothelial syndrome. Eur J Ophthalmol 30:Np25-np28. https://doi.org/10.1177/1120672118820508
doi: 10.1177/1120672118820508
pubmed: 30618278
Pathak Ray V, Rao DP, Gulati I (2019) Primary implantation of non-valved glaucoma-drainage-device in sulcus in iridocorneal endothelial syndrome. Int J Ophthalmol 12:1809–1811. https://doi.org/10.18240/ijo.2019.11.23
doi: 10.18240/ijo.2019.11.23
pubmed: 31741874
pmcid: 6848870
Bucher F, Dietlein T, Hermann M et al (2013) Retrocorneal membrane formation after Baerveldt shunt implantation for iridocorneal endothelial syndrome. Cornea 32:e161-163. https://doi.org/10.1097/ICO.0b013e31828989cd
doi: 10.1097/ICO.0b013e31828989cd
pubmed: 23538633
Deng Y, Zhang S, Ye W et al (2022) Achieving inner aqueous drain in glaucoma secondary to iridocorneal endothelial syndrome: One year results of penetrating canaloplasty. Am J Ophthalmol 243:83–90. https://doi.org/10.1016/j.ajo.2022.07.006
doi: 10.1016/j.ajo.2022.07.006
pubmed: 35870489
Feng B, Tang X, Sun X et al (2013) Analysis on misdiagnosis and missed diagnosis of iridocorneal endothelial syndrome. Zhonghua Yan Ke Za Zhi 49:637–641
pubmed: 24257361
Wu J, Dong X, Ouyang C et al (2021) Comparison of descemet membrane endothelial keratoplasty for iridocorneal endothelial syndrome and fuchs endothelial dystrophy. Am J Ophthalmol 226:76–82. https://doi.org/10.1016/j.ajo.2021.01.029
doi: 10.1016/j.ajo.2021.01.029
pubmed: 33556383
Laganowski HC, Kerr Muir MG, Hitchings RA (1992) Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol 110:346–350. https://doi.org/10.1001/archopht.1992.01080150044025
doi: 10.1001/archopht.1992.01080150044025
pubmed: 1543451
Zhang S, Hu C, Cheng H et al (2022) Efficacy of bleb-independent penetrating canaloplasty in primary angle-closure glaucoma: one-year results. Acta Ophthalmol 100:e213–e220. https://doi.org/10.1111/aos.14869
doi: 10.1111/aos.14869
pubmed: 33880864
Doe EA, Budenz DL, Gedde SJ et al (2001) Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome. Ophthalmology 108:1789–1795. https://doi.org/10.1016/s0161-6420(01)00725-4
doi: 10.1016/s0161-6420(01)00725-4
pubmed: 11581050
Kidd M, Hetherington J, Magee S (1988) Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol 106:199–201. https://doi.org/10.1001/archopht.1988.01060130209027
doi: 10.1001/archopht.1988.01060130209027
pubmed: 3341974
Kim DK, Aslanides IM, Schmidt CM Jr et al (1999) Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome. Ophthalmology 106:1030–1034. https://doi.org/10.1016/S0161-6420(99)00529-1
doi: 10.1016/S0161-6420(99)00529-1
pubmed: 10328409
Lin MM, Morgan WH, Kolomeyer NN et al (2020) XEN gel stent to treat ICE syndrome: 4 cases. J Glaucoma 29:e26. https://doi.org/10.1097/IJG.0000000000001449
doi: 10.1097/IJG.0000000000001449
pubmed: 32229787
Pathak Ray V, Rao DP (2018) Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2017-311716
doi: 10.1136/bjophthalmol-2017-311716
pubmed: 29945893
Campbell DG, Shields MB, Smith TR (1978) The corneal endothelium and the spectrum of essential iris atrophy. Am J Ophthalmol 86:317–324. https://doi.org/10.1016/0002-9394(78)90232-5
doi: 10.1016/0002-9394(78)90232-5
pubmed: 717494
Patel A, Kenyon KR, Hirst LW et al (1983) Clinicopathologic features of Chandler’s syndrome. Surv Ophthalmol 27:327–344. https://doi.org/10.1016/0039-6257(83)90234-5
doi: 10.1016/0039-6257(83)90234-5
pubmed: 6344293
Tsai CS, Ritch R, Straus SE et al (1990) Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome. Arch Ophthalmol 108:1572–1576. https://doi.org/10.1001/archopht.1990.01070130074034
doi: 10.1001/archopht.1990.01070130074034
pubmed: 2173898
Wilson MC, Shields MB (1989) A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol 107:1465–1468. https://doi.org/10.1001/archopht.1989.01070020539035
doi: 10.1001/archopht.1989.01070020539035
pubmed: 2803093
Matlach J, Dhillon C, Hain J et al (2015) Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial. Acta Ophthalmol 93:753–761. https://doi.org/10.1111/aos.12722
doi: 10.1111/aos.12722
pubmed: 25847610
pmcid: 6680218
Brusini P (2014) Canaloplasty in open-angle glaucoma surgery: a four-year follow-up. Sci World J 2014:469609. https://doi.org/10.1155/2014/469609
doi: 10.1155/2014/469609